We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
AUM
$736K
AUM Growth
+$3.29K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
1
Castle Biosciences
CSTL
$949M
$568K 77.21%
33,626
WHWK
2
Whitehawk Therapeutics
WHWK
$208M
$129K 17.55%
26,666
SYBX
3
DELISTED
Synlogic
SYBX
$38.6K 5.24%
13,727

Similar funds

ABG Innovation Capital Partners III's Q3 2023 Portfolio in Review

As of Q3 2023, ABG Innovation Capital Partners III held 3 positions worth $736K, up 0.45% from $732K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. ABG Innovation Capital Partners III opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $736K portfolio in Q3 2023.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 0 in Q3 2023.
  • ABG Innovation Capital Partners III's portfolio value rose 0.45% quarter-over-quarter to $736K.

Based on ABG Innovation Capital Partners III's 13F filing for Q3 2023, filed 14 Nov 2023.